Earth Science Tech (ETST) Total Current Liabilities (2012 - 2026)
Earth Science Tech's (ETST) quarterly Total Current Liabilities came in at $2.9 million in Q2 2026, down 15.49% on a YoY basis from $3.4 million in Q2 2025, and up 48.84% quarter-over-quarter from $1.9 million in Q1 2026.
Analysis
Earth Science Tech (ETST) Total Current Liabilities (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Total Current Liabilities for 13 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities fell 15.49% year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2026 stood at $2.9 million (down 15.49% YoY), and the FY2026 full-year result was $1.9 million, down 38.7% from the prior year.
- Total Current Liabilities rose to $2.9 million in Q2 2026 per ETST's latest filing, from $1.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $3.6 million in Q3 2025 and bottomed at $508850.0 in Q3 2023.
- Historically, Total Current Liabilities has averaged $2.0 million across 5 years, with a median of $1.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities sank 78.65% in 2023, then soared 233.95% in 2024.
- Over 5 years, Total Current Liabilities stood at $1.4 million in 2022, then sank by 41.38% to $825166.0 in 2023, then jumped by 180.5% to $2.3 million in 2024, then dropped by 2.36% to $2.3 million in 2025, then grew by 27.02% to $2.9 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.9 million, $1.9 million, and $2.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 15.65 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 6.35 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.66 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 883.19 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 4.54 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 331.18 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 283.66 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 263.21 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 12.39 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 2.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.87 Mn |
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Dec 31, 2024 | 2.31 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 825,166.00 |
| Sep 30, 2023 | 508,850.00 |
| Jun 30, 2023 | 962,509.00 |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 2.38 Mn |
| Jun 30, 2022 | 2.28 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 1.73 Mn |